company background image
0J5Q logo

Hologic LSE:0J5Q Stock Report

Last Price

US$77.11

Market Cap

US$18.2b

7D

2.2%

1Y

-3.5%

Updated

28 Mar, 2024

Data

Company Financials +

0J5Q Stock Overview

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment.

0J5Q fundamental analysis
Snowflake Score
Valuation4/6
Future Growth3/6
Past Performance1/6
Financial Health6/6
Dividends0/6

Hologic, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Hologic
Historical stock prices
Current Share PriceUS$77.11
52 Week HighUS$86.55
52 Week LowUS$64.69
Beta1.0
1 Month Change2.32%
3 Month Change8.69%
1 Year Change-3.55%
3 Year Change2.51%
5 Year Change59.81%
Change since IPO77.75%

Recent News & Updates

Recent updates

Shareholder Returns

0J5QGB Medical EquipmentGB Market
7D2.2%1.4%2.3%
1Y-3.5%3.6%2.7%

Return vs Industry: 0J5Q underperformed the UK Medical Equipment industry which returned 2.3% over the past year.

Return vs Market: 0J5Q underperformed the UK Market which returned 3.7% over the past year.

Price Volatility

Is 0J5Q's price volatile compared to industry and market?
0J5Q volatility
0J5Q Average Weekly Movement2.5%
Medical Equipment Industry Average Movement7.6%
Market Average Movement4.8%
10% most volatile stocks in GB Market11.3%
10% least volatile stocks in GB Market2.5%

Stable Share Price: 0J5Q has not had significant price volatility in the past 3 months.

Volatility Over Time: 0J5Q's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19856,990Steve MacMillanhttps://www.hologic.com

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth.

Hologic, Inc. Fundamentals Summary

How do Hologic's earnings and revenue compare to its market cap?
0J5Q fundamental statistics
Market capUS$18.16b
Earnings (TTM)US$515.10m
Revenue (TTM)US$3.97b

35.2x

P/E Ratio

4.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
0J5Q income statement (TTM)
RevenueUS$3.97b
Cost of RevenueUS$1.55b
Gross ProfitUS$2.42b
Other ExpensesUS$1.91b
EarningsUS$515.10m

Last Reported Earnings

Dec 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)2.19
Gross Margin60.99%
Net Profit Margin12.98%
Debt/Equity Ratio55.0%

How did 0J5Q perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.